Company · Ownership research

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA

CIK 0000818686

Form 4 transactions dated Oct 1, 2023 to Oct 15, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 115 rows; the complete set is available through the API.

Insider filings on file run through Sep 22, 2026.

Insider purchases & sales

Purchased: $20.99K
Sold: $160.72M

Oct 1, 2023 – Sep 22, 2026
Available records · partial months are marked ·

Insiders in this window

202410 of 24 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 20, 2024	MIGNONE ROBERTO Director	Sale	$6.29M 286,000 shares sold	29.15% sold Indirect holding	▾
Nov 20, 2024	Fox Christine EVP, Head of U.S. Commercial	Sale10b5-1 footnote	$327.09K 19,388 shares sold	30.54% sold Direct holding	▾
Aug 12, 2024	Daniell Richard Exec. VP, European Commercial	Sale	$1.71M 98,943 shares sold	100.00% sold Direct holding	▾
Aug 9, 2024	Grant Angus EVP, Business Development	Sale10b5-1 footnote	$70.24K 4,065 shares sold	31.48% sold Direct holding	▾
Aug 9, 2024	Hughes Eric A See "Remarks"	Sale	$782.97K 45,060 shares sold	100.00% sold Direct holding	▾
Aug 1, 2024	Hughes Eric A See "Remarks"	Sale10b5-1 footnote	$423.28K 24,537 shares sold	35.26% sold Direct holding	▾
Jun 18, 2024	MIGNONE ROBERTO Director	Sale	$8.84M 519,000 shares sold	34.60% sold Indirect holding	▾
May 16, 2024	Weiss Amir Chief Accounting Officer	Sale	$210.38K 12,635 shares sold	70.93% sold Direct holding	▾
May 15, 2024	Weiss Amir Chief Accounting Officer	Sale	$260.42K 15,500 shares sold	46.53% sold Direct holding	▾
May 13, 2024	Conway Vikki L See "Remarks"	Sale	$254.81K 15,219 shares sold	100.00% sold Direct holding	▾

Showing 24 / 24 record groups in 2024. The complete set is available through the API.

TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 24 of 24 purchase / sale groups and 30 of 115 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"TEVA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.